PDGF and Proliferative Vitreoretinopathy
PDGF和增殖性玻璃体视网膜病变
基本信息
- 批准号:7273521
- 负责人:
- 金额:$ 47.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-08-01 至 2009-07-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAnimalsCellsChimera organismClinicalDevelopmentDiseaseDisease modelEpiretinal MembraneEpithelialEventExtracellular DomainFamily memberFibroblastsFutureGoalsGrantGrowth FactorHumanLigandsModelingMolecularNumbersOperative Surgical ProceduresOryctolagus cuniculusOutcome StudyPatientsPlatelet-Derived Growth FactorPlatelet-Derived Growth Factor ReceptorPlayProliferative VitreoretinopathyProtein IsoformsReportingRetinalRetinal PigmentsRoleRouteSignal PathwayStructure of retinal pigment epitheliumTestingTransforming Growth Factor betaTransforming Growth Factorsbasecell typehuman diseaseimprovedinsightneutralizing antibodypreventreceptorresearch study
项目摘要
DESCRIPTION (provided by applicant): Our findings in the previous grant period included that platelet-derived growth factor (PDGF) receptors (PDGFRs) are present in epiretinal membranes of human proliferative vitreoretinopathy (PVR) donors, and that PDGFRs are required for development of PVR in a rabbit model of the disease. We will continue to investigate the role of PDGF in PVR as outlined in these specific aims:
1. To investigate why the alphaPDGFR is better at causing PVR than the betaPDGFR. In the rabbit model of PVR, cells expressing the alphaPDGFR induce PVR much more effectively than do the same cells expressing the betaPDGFR. We will identify the region(s) of the alphaPDGFR that enable the betaPDGFR to induce PVR by using chimeras of the alpha and betaPDGFRs.
2. Test the hypothesis that TGFbeta activates the alphaPDGFR via PDGF-CC. Activation of the PDGFR is a
prerequisite for PVR in rabbits, and in this aim we will test whether our recently discovered unconventional, transforming growth factor beta (TGFbeta)-dependent route to activate the alphaPDGFR is dependent on PDGF-CC.
3. Identify factors that augment the PVR potential of retinal pigment epithelial cells (RPEs). While fibroblasts efficiently induce PVR in our rabbit model, RPE cells do not. This deficiency will be exploited to identify factors that elevate the PVR potential of RPE cells.
4. Screen epiretinal membranes from human PVR donors for expression of factors that promote PVR in the animal model. We will screen epiretinal membranes from human PVR donors for the expression of factors that are critical for PVR in the rabbit model (like alphaPDGFR, activated alphaPDGFR and ligands for this receptor).
Together these studies will identify factors that promote PVR and elucidate the relationships between such factors. In addition, our finding will critically evaluate the relevance of the rabbit model to human disease. This information will guide future efforts to develop approaches to prevent and/or treat PVR in humans.
描述(由申请人提供):我们在上一个资助期的发现包括血小板衍生生长因子(PDGF)受体(PDGFRs)存在于人增生性玻璃体视网膜病变(PVR)供体的视网膜前膜中,并且PDGFRs是该疾病兔模型中PVR发展所必需的。我们将继续研究PDGF在PVR中的作用,具体目标如下:
1.研究为什么α PDGFR比β PDGFR更能引起PVR。在兔PVR模型中,表达α PDGFR的细胞比表达β PDGFR的相同细胞更有效地诱导PVR。我们将通过使用α和β PDGFRs的嵌合体来识别使β PDGFRs能够诱导PVR的α PDGFRs区域。
2.检验TGF β通过PDGF-CC激活α PDGFR的假设。PDGFR的激活是
因此,我们将测试我们最近发现的非常规的、转化生长因子β(TGF β)依赖性的激活α PDGFR的途径是否依赖于PDGF-CC。
3.确定增加视网膜色素上皮细胞(RPE)PVR潜力的因素。虽然成纤维细胞在我们的兔模型中有效地诱导PVR,但RPE细胞不能。这一缺陷将被用来确定提高RPE细胞PVR潜力的因素。
4.在动物模型中筛选来自人类PVR供体的视网膜前膜中促进PVR的因子的表达。我们将在兔模型中筛选人PVR供体的视网膜前膜中对PVR至关重要的因子(如α PDGFR、活化的α PDGFR和该受体的配体)的表达。
这些研究将共同确定促进PVR的因素,并阐明这些因素之间的关系。此外,我们的发现将严格评估兔子模型与人类疾病的相关性。这些信息将指导未来的努力,以开发方法来预防和/或治疗PVR的人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDRIUS KAZLAUSKAS其他文献
ANDRIUS KAZLAUSKAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDRIUS KAZLAUSKAS', 18)}}的其他基金
Signaling events that control the fate of existing vessels
控制现有船只命运的信号事件
- 批准号:
7296206 - 财政年份:2007
- 资助金额:
$ 47.58万 - 项目类别:
A GENE THERAPY-BASED APPROACH TO PREVENT PVR
基于基因治疗的预防 PVR 的方法
- 批准号:
6641237 - 财政年份:2000
- 资助金额:
$ 47.58万 - 项目类别:
A GENE THERAPY-BASED APPROACH TO PREVENT PVR
基于基因治疗的预防 PVR 的方法
- 批准号:
6196190 - 财政年份:2000
- 资助金额:
$ 47.58万 - 项目类别:
A GENE THERAPY-BASED APPROACH TO PREVENT PVR
基于基因治疗的预防 PVR 的方法
- 批准号:
6524964 - 财政年份:2000
- 资助金额:
$ 47.58万 - 项目类别:
A GENE THERAPY-BASED APPROACH TO PREVENT PVR
基于基因治疗的预防 PVR 的方法
- 批准号:
6384797 - 财政年份:2000
- 资助金额:
$ 47.58万 - 项目类别:
相似海外基金
RNA/RNP-chemogenetics for living cells and animals
活细胞和动物的 RNA/RNP 化学遗传学
- 批准号:
22H02608 - 财政年份:2022
- 资助金额:
$ 47.58万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Generation of pancreas from human iPS cells using in vivo environment of experimental animals
利用实验动物体内环境从人 iPS 细胞生成胰腺
- 批准号:
21K19506 - 财政年份:2021
- 资助金额:
$ 47.58万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
FMRG: Genetically-targeted chemical assembly (GTCA) of functional structures in living cells, tissues, and animals
FMRG:活细胞、组织和动物功能结构的基因靶向化学组装 (GTCA)
- 批准号:
2037164 - 财政年份:2020
- 资助金额:
$ 47.58万 - 项目类别:
Standard Grant
Identification of senescent cells in the tissues of aged animals and the effect of their removal on prolonging individual life span.
鉴定老年动物组织中的衰老细胞以及去除它们对延长个体寿命的影响。
- 批准号:
19H04043 - 财政年份:2019
- 资助金额:
$ 47.58万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Preclinical efficacy study of novel carrier cells for refractory solid tumors in companion animals
新型载体细胞治疗伴侣动物难治性实体瘤的临床前疗效研究
- 批准号:
17K11279 - 财政年份:2017
- 资助金额:
$ 47.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of new procedure to make chimeric animals without using naive pluripotent stem cells
开发新程序在不使用幼稚多能干细胞的情况下制造嵌合动物
- 批准号:
15K20948 - 财政年份:2015
- 资助金额:
$ 47.58万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Establishment of an efficient maintenance and expansion system for spermatogonial stem cells from wide variety of animals.
建立来自多种动物的精原干细胞的有效维持和扩增系统。
- 批准号:
26712026 - 财政年份:2014
- 资助金额:
$ 47.58万 - 项目类别:
Grant-in-Aid for Young Scientists (A)
Articular cartilage regeneration by transplantation of aggregates of synovial mesenchymal stem cells in large animals
大型动物滑膜间充质干细胞聚集体移植促进关节软骨再生
- 批准号:
26861173 - 财政年份:2014
- 资助金额:
$ 47.58万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Real-time tracking of single cells in live animals
实时追踪活体动物的单细胞
- 批准号:
8930185 - 财政年份:2014
- 资助金额:
$ 47.58万 - 项目类别:
Real-time tracking of single cells in live animals
实时追踪活体动物的单细胞
- 批准号:
8828429 - 财政年份:2014
- 资助金额:
$ 47.58万 - 项目类别: